21. Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours. (May 2018) Authors: Herin, H.; Aspeslagh, S.; Castanon, E.; Dyevre, V.; Marabelle, A.; Varga, A.; Postel Vinay, S.; Michot, J.M.; Ribrag, V.; Gazzah, A.; Bahleda, R.; Mir, O.; Massard, C.; Hollebecque, A.; Soria, J.C.; Baldini, C. Journal: European journal of cancer Issue: Volume 95(2018) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. OC-014: Molecular screening for cancer treatment optimization in head and neck cancer (MOSCATO 01). (February 2015) Authors: Even, C.; Breuskin, I.; Ileana, E.; Massard, C.; Lacroix, L.; Lezghed, N.; Guigay, J.; Janot, F.; Soria, J.C.; Ferté, C. Journal: Radiotherapy and oncology Issue: Volume 114(2015:Jan.)Supplement 1 Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression. (September 2018) Authors: Bernard-Tessier, A.; Baldini, C.; Martin, Patricia; Champiat, Stéphane; Hollebecque, Antoine; Postel-Vinay, Sophie; Varga, Andrea; Bahleda, Rastilav; Gazzah, Anas; Michot, Jean-Marie; Ribrag, Vincent; Armand, Jean-Pierre; Marabelle, Aurélien; Soria, Jean-Charles; Massard, C. Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. PD-0425: Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies. (November 2020) Authors: Sun, R.; Sundahl, N.; Hecht, M.; Putz, F.; Lancia, A.; Milic, M.; Carré, A.; Lerousseau, M.; Theo, E.; Battistella, E.; Andres, E. Alvarez; Louvel, G.; Durand-Labrunie, J.; Bockel, S.; Bahleda, R.; Robert, C.; Boutros, C.; Vakalopoulou, M.; Paragios, N.; Frey, B. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours. (August 2017) Authors: Hollebecque, A.; Bahleda, R.; Faivre, L.; Adam, J.; Poinsignon, V.; Paci, A.; Gomez-Roca, C.; Thery, J.C.; Le Deley, M.C.; Varga, A.; Gazzah, A.; Ileana, E.; Gharib, M.; Angevin, E.; Malekzadeh, K.; Massard, C.; Soria, J.C.; Spano, J.P. Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. (18th October 2016) Authors: Massard, C.; Mateo, J.; Loriot, Y.; Pezaro, C.; Albiges, L.; Mehra, N.; Varga, A.; Bianchini, D.; Ryan, C. J.; Petrylak, D. P.; Attard, G.; Shen, L.; Fizazi, K.; de Bono, J. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. PO-1227: A dose escalation phase 1 study of radiotherapy combined with ipilimumab in metastatic melanoma. (November 2020) Authors: Boutros, C.; Chaput, N.; Lanoy, E.; Larive, A.; Mateus, C.; Routier, E.; Roy, S.; Sun, R.; Lancia, A.; Tao, Y.G.; Ibrahim, N.; Khoury-Abboud, R.; Massard, C.; Bahleda, R.; Schwob, D.; Caramella, C.; Cassard, L.; Soria, J.; Robert, C.; Deutsch, E. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. SAFETY PROFILE OF COMBINATION THERAPY WITH IMMUNE CHECKPOINT BLOCKERS AND VEGF INHIBITORS IN OLDER PATIENTS TREATED IN EARLY PHASE CLINICAL TRIALS. (November 2019) Authors: Baldini, C.; Romano, P.Martin; Vincent, H.; Vuagnat, P.; Champiat, S.; Michot, J.; Bahleda, R.; Gazzah, A.; Vinay, S.Postel; Hollebecque, A.; Angevin, E.; Ribrag, V.; Loriot, Y.; Marabelle, A.; Massard, C.; Varga, A. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Use of the Geriatric Core Dataset for older patients included in early phase trials. (October 2022) Authors: Seknazi, L.; Goldschmidt, V.; Champiat, S.; Hollebecque, A.; Martin-Romano, P.; Bahleda, R.; Gazzah, A.; Michot, J.M.; Sarkozy, C.; Vuagnat, P.; Ouali, K.; Bayle, A.; Danlos, F.X.; Mahjoubi, L.; Massard, C.; Ponce Aix, S.; Paillaud, E.; Baldini, C. Journal: Journal of geriatric oncology Issue: Volume 13(2022)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer. Issue 1 (December 2016) Authors: Lindsay, C.; Le Moulec, S.; Billiot, F.; Loriot, Y.; Ngo-Camus, M.; Vielh, P.; Fizazi, K.; Massard, C.; Farace, F. Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗